BANGKOK -- Thai biopharmaceutical company Siam Bioscience has signed an agreement to partner with U.K.-based drug major AstraZeneca to produce and supply potential COVID-19 vaccine AZD1222, developed by the University of Oxford, for Thailand and Southeast Asian countries.
Coronavirus
Siam Bioscience to produce Oxford COVID-19 vaccine for ASEAN
Thai company receives tech transfer from AstraZeneca for launch by mid-2021
Siam Bioscience will set up production facilities for a potential COVID-19 vaccine developed by the University of Oxford. © Reuters
Read Next
Latest on Coronavirus
